FMC Corporation Q1 2009 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2009. FMC Corporation is a diversified, global chemical company operating in three segments: Agricultural Products, Specialty Chemicals, and Industrial Chemicals. The company reported 72,675,293 shares of common stock outstanding as of the period end.
Key Financial Metrics
| Metric | Q1 2009 | Q1 2008 |
|---|---|---|
| Revenue | $690.5 million | $750.2 million |
| Net Income (Attributable to FMC) | $69.1 million | $93.9 million |
| Diluted EPS | $0.94 | $1.23 |
| Operating Cash Flow | $24.8 million | ($54.5 million) |
| Total Debt | $668.2 million | $623.6 million |
| Cash and Equivalents | $54.9 million | $70.4 million |
| Effective Tax Rate | 30.7% | 29.0% |
Material Changes vs. Prior Period
- Revenue Decline: Consolidated revenue decreased 8% year-over-year. Industrial Chemicals saw the largest drop (12%), followed by Specialty Chemicals (5%) and Agricultural Products (6%).
- Profitability: Net income declined 26% to $69.1 million. This was driven by a 36% drop in Industrial Chemicals operating profit and significant restructuring charges.
- Restructuring Charges: The company recorded $22.5 million in restructuring and other charges in Q1 2009, compared to a net gain of $8.3 million in Q1 2008. The 2008 gain was largely due to asset sales (Princeton property and sodium sulfate assets) which did not recur in 2009.
- Cash Flow Improvement: Operating cash flow turned positive ($24.8 million) compared to a cash outflow of $54.5 million in the prior year, primarily due to reduced receivables and the absence of large asset sale proceeds in 2008.
Guidance, Outlook, and Risks
- Segment Outlook:
- Agricultural Products: Full-year revenue expected to grow in the mid-single digits; operating profit expected to increase in the low-to-mid teens.
- Specialty Chemicals: Full-year revenue expected to grow in the low single digits; operating profit expected to increase in the mid-single digits.
- Industrial Chemicals: Full-year revenue expected to decline 10-15%; operating profit expected to decline 20-30% due to volume declines and higher raw material costs.
- Restructuring Actions: The company announced shutdowns of the Santa Clara (Mexico) Peroxygens facility and the Bayport (Texas) butyllithium facility to improve cost competitiveness. Realignment of BioPolymer alginates operations is also underway.
- Legal and Regulatory Risks:
- European Commission: FMC is appealing a €25.0 million fine regarding hydrogen peroxide competition law violations. Interest accrues at 4.0% per annum. A new investigation into animal feed phosphates was initiated in January 2009.
- Antitrust Litigation: FMC reached a preliminary settlement of $10 million for U.S. hydrogen peroxide class action claims. Canadian class actions remain pending.
- Regulatory: EPA and EU reviews of key products (carbofuran, bifenthrin) continue, with potential impacts on sales if tolerances are revoked or approvals denied.
- Liquidity: The company maintains strong liquidity with $370 million in available credit facilities and $54.9 million in cash. Leverage ratio is 1.2x (well within the 3.5x covenant limit).
Investor Verification Checklist
- Verify the impact of the European Commission fine and the status of the new phosphate investigation on future cash flows and reserves.
- Monitor the regulatory status of carbofuran (EPA) and bifenthrin (EU) to assess potential revenue risks in the Agricultural Products segment.
- Review the execution of cost-saving initiatives at the Santa Clara and Bayport facilities to ensure projected savings materialize.
- Assess the volume trends in the Industrial Chemicals segment, particularly in soda ash and hydrogen peroxide, given the 12% revenue decline.
- Confirm the tax benefit realization in Q2 2009, as management expects a $17 million reduction in unrecognized tax benefits.